PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
This systemic reaction, also known as the Herxheimer's reaction, was classically described in the treatment of syphilis. It is believed to be caused by the release of endotoxin-like substances when large numbers of Treponema pallidum are killed by antibiotics. It has been documented in tick-borne diseases like Lyme disease, leptospirosis and relapsing fever, all of which are spirochaetal organisms. One study suggested that it was more common in Lyme disease patients treated with cefuroxime. The mechanism may not be straightforward as it is not a feature of neonatal syphilis or non-venereal syphilis in childhood. The reaction can be expected in 50-75% of primary or secondary syphilis, and in 16% of early latent infection but is very rare in late syphilis. It has been suggested that it is more severe in patients with HIV.
Add notes to any clinical page and create a reflective diary
Automatically track and log every page you have viewed
Print and export a summary to use in your appraisal
- The reaction starts between 1 and 12 hours after the first injection of antibiotics and lasts for a few hours or up to a day.
- It is not seen with subsequent treatment.
- There is malaise, slight-to-moderate pyrexia, a flush due to vasodilation, tachycardia and leukocytosis.
- Any existing skin lesions become more prominent.
- Hyperventilation and tachycardia are accompanied by hypertension and then by a drop in blood pressure due to vasodilation and declining peripheral resistance.
- In some patients with early syphilis, a secondary rash may become visible which was absent before treatment.
- Usually, the reaction resolves over a period of 6-12 hours.
It is important to recognise the reaction for what it is and not to ascribe it to a sensitivity to the antibiotic. Rarely, syphilis may be suspected by the appearance of the febrile reaction of the Jarisch-Herxheimer, perhaps with a fleeting rash, when treating another infection such as gonorrhoea. It is important to recognise this and to make the diagnosis and give an adequate course for syphilis.
Usually no investigation is required but if an unexpected reaction to antibiotic treatment occurs then serological tests for syphilis are required.
For many years there has been a suggestion that mycoplasma may be involved in the aetiology of rheumatoid arthritis and other autoimmune diseases including sarcoidosis. Propionibacterium acnes has been identified as a possible causative organism in sarcoidosis. The Jarisch-Herxheimer reaction sometimes occurs after antibiotic treatment and the severity of the reaction is taken as evidence that the treatment is working.
No treatment is usually required for the reaction per se, which is self-limiting and often resolves within 24 hours.
Treatment of severe leptospirosis-related Jarisch-Herxheimer reaction with fluid infusion, vasopressors, corticosteroids, inotropic support and transient dialysis has been reported.
Various measures can be taken to reduce the risk of the reaction or ameliorate its effects.
Judicious selection of antibiotics with a lower risk of Jarisch-Herxheimer reaction is helpful if the clinical situation allows it - eg, azithromycin therapy in HIV-positive patients with early syphilis.
It is customary to give corticosteroids in late symptomatic syphilis, starting a day before the first penicillin injection and tailing it off the day after the first injection. A dose of around 30 mg prednisolone is typical. This does not prevent the Jarisch-Herxheimer reaction but is said to ameliorate it. One study showed that treatment with anti-TNF-alpha Fab antibody fragments reduced the frequency of the Jarisch-Herxheimer reaction from 90-50%. Anti-TNF-alpha-treated patients had significantly lower increases in temperature, pulse rate and systolic blood pressure and lower plasma concentrations of interleukin 6 and 8 after treatment with penicillin.
In pregnancy the incidence of the reaction when treating syphilis is about 40%. Fetal monitoring should be performed, as similar proportions of patients develop regular uterine contractions and recurrent variable decelerations. A review of the literature found conflicting evidence that the reaction is caused by release of endotoxin-like material from the spirochete as well as cytokine elevation in the body. The type of drug and the rate of clearance of the spirochetes have little effect on the incidence of the reaction. Many pre-treatment options have been explored with limited efficacy with the exception of anti-TNF antibodies.
In early syphilis the reaction is only a minor nuisance. In late syphilis it can, on very rare occasions, be more serious. Thus, in neurosyphilis it may lead to epilepsy or a rapid, irreversible progression and in general paresis it can cause exacerbation amounting to temporary psychosis. Sudden death has been reported in cardiovascular syphilis. In laryngeal gumma, local oedema may necessitate tracheotomy. In the later stages of pregnancy fetal monitoring is advised.
Recovery is usually swift and the course of treatment is completed.
Adolf Jarisch (1850-1902) was an Austrian dermatologist. Jarisch published his description of the Jarisch-Herxheimer reaction in 1895, seven years before Herxheimer published his own description. As this was many years before the discovery of penicillin, the original description related to the treatment with mercury.
Karl Herxheimer (1861-1942) was a German dermatologist. Herxheimer published his description of the Jarisch-Herxheimer reaction in 1902. He had already resigned his positions because of his age when the Nazis took power in 1933 but, despite being Jewish, he stubbornly refused to leave his native country. He was imprisoned in the autumn of 1941 and on August 27 1942, aged 81, he died in a concentration camp.
Further reading & references
- Punia V, Rayi A, Sivaraju A; Stroke after Initiating IV Penicillin for Neurosyphilis: A Possible Jarisch-Herxheimer Reaction. Case Rep Neurol Med. 2014;2014:548179. doi: 10.1155/2014/548179. Epub 2014 Nov 5.
- Hoekstra KA, Kelly MT; Elevated troponin and jarisch-herxheimer reaction in tick-borne relapsing Fever: a case report. Case Rep Infect Dis. 2011;2011:950314. doi: 10.1155/2011/950314. Epub 2011 Oct 9.
- Loewen PS, Marra CA, Marra F; Systematic review of the treatment of early Lyme disease.; Drugs. 1999 Feb;57(2):157-73.
- Tsai MS, Yang CJ, Lee NY, et al; Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy. J Int AIDS Soc. 2014 Aug 28;17:18993. doi: 10.7448/IAS.17.1.18993. eCollection 2014.
- Li J, Wang LN, Zheng HY; Jarisch-Herxheimer reaction among syphilis patients in China. J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1304-7. doi: 10.1111/j.1468-3083.2012.04544.x. Epub 2012 May 21.
- Eishi Y; Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int. 2013;2013:935289. doi: 10.1155/2013/935289. Epub 2013 Jun 16.
- Marshall TG, Marshall FE; Sarcoidosis succumbs to antibiotics--implications for autoimmune disease.; Autoimmun Rev. 2004 Jun;3(4):295-300.
- Guerrier G, D'Ortenzio E; The Jarisch-Herxheimer reaction in leptospirosis: a systematic review. PLoS One. 2013;8(3):e59266. doi: 10.1371/journal.pone.0059266. Epub 2013 Mar 26.
- Syphilis Infection; BMJ Best Practice, 2015 (Sign-in required)
- Gelderblom H, Schmidt J, Londono D, et al; Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol. 2007 Jan;170(1):251-62.
- Wilson C et al; Remington and Klein's Infectious Diseases of the Fetus and Newborn
- De Santis M, De Luca C, Mappa I, et al; Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012;2012:430585. doi: 10.1155/2012/430585. Epub 2012 Jul 4.
- Pound MW, May DB; Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions.; J Clin Pharm Ther. 2005 Jun;30(3):291-5.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
Dr Richard Draper
Dr Laurence Knott
Dr Adrian Bonsall